[1] Kim J, Harper A, Mccormack V, et al.Global patterns and trends in breast cancer incidence and mortality across 185 countries[J]. Nat Med, 2025, 31(4): 1154-1162. [2] Bray F, Laversanne M, Sung H, et al.Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. [3] Han B, Zheng R, Zeng H, et al.Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent, 2024, 4(1): 47-53. [4] 邬昊, 吕青. 全球及中国乳腺癌的流行病学趋势及防控启示:2018-2022年《全球癌症统计报告》解读[J]. 中国普外基础与临床杂志, 2024, 31(7): 796-802. [5] 曹毛毛, 陈万青. 中国癌症筛查现状[J]. 科技导报, 2023, 41(18): 11-17. [6] 曹希, 骆勇超, 沈松杰. 适合中国女性的乳腺癌筛查策略[J]. 外科理论与实践, 2024, 29(5): 382-388. [7] Molassiotis A, Tyrovolas S, Giné-Vázquez I, et al.Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Disease Study and screening programme availability in 130 countries[J]. ESMO Open, 2021, 6(3): 100111. [8] 武丽, 陈国珍, 马远珠, 等. 2021年广东省35~64岁适龄妇女乳腺癌筛查现状分析[J]. 中国妇幼健康研究, 2023, 34: 51-58. [9] 何琴, 陈国珍, 武丽, 等. 乳腺肿块超声特征在乳腺癌筛查中的预测价值分析[J]. 中国妇幼卫生杂志, 2024, 15: 73-80. [10] Dekker BMD, Broeders MJM, Meeuwis C, et al.Diagnostic accuracy of supplemental three-dimensional breast ultrasound in the work-up of BI-RADS 0 screening recalls[J]. Insights Imaging, 2024, 15(1): 131. [11] Spear G, Lee K, Depersia A, et al.Updates in Breast Cancer Screening and Diagnosis[J]. Curr Treat Options Oncol, 2024, 25(11): 1451-1460. [12] 国务院第七次全国人口普查领导小组办公室. 第七次全国人口普查主要数据 [M/OL]. 北京: 中国统计出版社, 2021. https://www.stats.gov.cn/sj/pcsj/rkpc/d7c/202303/P020230301403217959330.pdf [13] Li H, Huang M, Yang Y, et al.The Practice and Willingness of Women Towards Opportunistic Screening for Breast and Cervical Cancers in Sichuan Province, China: A Cross-Sectional Study[J]. Risk Manag Healthc Policy, 2023, 16: 169-183. [14] 岳璐, 吕艳丽, 赵雪莲, 等. 2016-2023年北京市顺义区35~64岁女性乳腺癌筛查现状分析[J]. 中国预防医学杂志, 2025, 26: 358-364. [15] 曹清芸, 王兵, 徐旭. 6620例早、中期妊娠妇女不同年龄段全血微量元素分析[J]. 中国计划生育学杂志, 2019, 27(7): 952-954. [16] 郭苗苗, 许丹丹, 严婷婷, 等. 基于数据挖掘的乳腺癌机会性筛查管理系统构建与应用[J]. 护理学杂志, 2025, 40(5): 104-107. [17] Noguchi N, Marinovich ML, Wylie EJ, et al.Screening outcomes by risk factor and age: evidence from BreastScreen WA for discussions of risk-stratified population screening[J]. Med J Aust, 2021, 215(8): 359-365. [18] 魏巍, 张妍, 张月, 等. 2011至2020年北京市妇女乳腺癌筛查状况分析[J]. 中国妇幼健康研究, 2022, 33: 101-107. [19] 文永春, 周戴, 肖亚玲. 2018—2023年长沙市适龄妇女宫颈癌和乳腺癌免费检查项目的成本效果分析[J]. 湖南师范大学学报(医学版), 2024, 21(6): 125-129. [20] Eisemann N, Bunk S, Mukama T, et al.Nationwide real-world implementation of AI for cancer detection in population-based mammography screening[J]. Nat Med, 2025, 31(3): 917-924. [21] Talley M, Starzyk K, Pohlman S, et al.Mammography screening outcomes for women screened by standard versus high resolution digital breast tomosynthesis[J]. Clin Imaging, 2025, 125: 110 553. [22] Ghias Khan ZaB, Muzammil. Diagnostic Accuracy of Ultrasonography in the Diagnosis of Breast Carcinoma in Mammographically Dense Breasts[J]. Gyn Obs, 2023, 3: 398. [23] Sood R, Rositch AF, Shakoor D, et al.Ultrasound for Breast Cancer Detection Globally: A Systematic Review and Meta-Analysis[J]. J Glob Oncol, 2019, 5: 1-17. [24] 沈松杰, 孙强, 黄欣, 等. 中国女性乳腺癌筛查指南(2022年版)[J]. 中国研究型医院, 2022, 9: 6-13. [25] 黄佳囡, 包凌云. 乳腺密度与乳腺癌风险相关性的影像学研究进展[J]. 浙江医学, 2025, 47(16): 1776-1781. [26] Hill H, Roadevin C, Duffy S, et al.Cost-Effectiveness of AI for Risk-Stratified Breast Cancer Screening[J]. JAMA Netw Open, 2024, 7(9): e2431715. [27] 刘新杰周, 马捷. 乳腺X线立体定位穿刺活检术对乳腺隐匿性病灶的诊断价值[J]. 陕西医学杂志, 2003, 32(05): 397-398. [28] Chotai N, Renganathan R, Uematsu T, et al.Breast Cancer Screening in Asian Countries: Epidemiology, Screening Practices, Outcomes, Challenges, and Future Directions[J]. Korean J Radiol, 2025, 26(8): 743-758. [29] Farkas AH, Nattinger AB. Breast Cancer Screening and Prevention [J]. Ann Intern Med, 2023, 176(11): ITC161-ITC176. [30] 中国抗癌协会乳腺癌整合防筛专业委员会.中国致密型乳腺女性乳腺癌筛查专家共识(2025年版)[J]. 中国普外基础与临床杂志, 2025, 32(11): 1345-1360. |